Publicaciones en colaboración con investigadores/as de Erasmus University Rotterdam (27)

2024

  1. Sustainable consumer behavior in fashion: Enabling and disabling factors

    Sustainability and the Fashion Industry: Can Fashion Save the World? (Taylor and Francis Ltd), pp. 175-200

2023

  1. Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results

    EJHAEM, Vol. 4, Núm. 4, pp. 1117-1131

2022

  1. Reference-dependent age weighting of quality-adjusted life years

    Health Economics (United Kingdom), Vol. 31, Núm. 12, pp. 2515-2536

  2. The Role of Perceived Utility of Full Health in Age Weighting

    Value in Health, Vol. 25, Núm. 9, pp. 1559-1565

2021

  1. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation

    Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321

2020

  1. Entrepreneurial identity development through digital media

    Journal of Media Business Studies, Vol. 17, Núm. 2, pp. 87-112

2018

  1. Peer effects in health valuation: The relation between rating of contemporaries' health and own health

    Health and Quality of Life Outcomes, Vol. 16, Núm. 1

  2. SEGMENTATION OF ACTIN-STAINED 3D FLUORESCENT CELLS WITH FILOPODIAL PROTRUSIONS USING CONVOLUTIONAL NEURAL NETWORKS

    2018 IEEE 15TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2018)

2016

  1. An elicitation of utility for quality of life under prospect theory

    Journal of Health Economics, Vol. 48, pp. 121-134

  2. From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries

    Social Science and Medicine, Vol. 166, pp. 205-213

2015

  1. Comparing WTP values of different types of QALY gain elicited from the general public

    Health Economics (United Kingdom), Vol. 24, Núm. 3, pp. 280-293

  2. Estimating sign-dependent societal preferences for quality of life

    Journal of Health Economics, Vol. 43, pp. 229-243

2014

  1. Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals

    European Journal of Nuclear Medicine and Molecular Imaging

2009

  1. New evidence of preference reversals in health utility measurement

    Health Economics, Vol. 18, Núm. 6, pp. 713-726

2007

  1. Resolving inconsistencies in utility measurement under risk: Tests of generalizations of expected utility

    Management Science, Vol. 53, Núm. 3, pp. 469-482

2005

  1. The validity of QALYS under non-expected utility

    Economic Journal, Vol. 115, Núm. 503, pp. 533-550

2003

  1. A consistency test of the time trade-off

    Journal of Health Economics, Vol. 22, Núm. 6, pp. 1037-1052

  2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group

    British Journal of Haematology, Vol. 121, Núm. 5, pp. 749-757

  3. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: Immunobiological characteristics and clinical implications

    Leukemia, Vol. 17, Núm. 7, pp. 1398-1403

  4. The value of SKU rationalization in practice (the pooling effect under suboptimal inventory policies and nonnormal demand)

    Production and Operations Management, Vol. 12, Núm. 1, pp. 12-29